Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
FDA signs off on Enflonsia, Merck's RSV shot for infants
The FDA has blessed Merck’s clesrovimab to protect against lower respiratory tract disease related to RSV in newborns and infants.
Kevin Dunleavy
Jun 9, 2025 4:33pm
7 top pharmas posted revenue declines in Q1, all from US
May 27, 2025 11:22am
AZ, Merck duke it out to lead oncologists’ pharma perceptions
May 22, 2025 10:54am
IDEA ranks Lilly, AZ as biopharma's top innovators, inventors
May 20, 2025 9:00am
Keytruda delivers trial win in some patients with ovarian cancer
May 15, 2025 10:56am
FDA signs off on Merck’s Welireg to treat adrenal system tumors
May 15, 2025 10:43am
